M. Francis and D. Velent, Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases, J Musculoskeletal Neuronal Interact, vol.7, pp.2-8, 2007.

A. Roelofs, K. Thompson, F. Ebetino, M. Rogers, and F. Coxon, Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages, Current Pharmaceutical Design, vol.16, issue.27, 2010.
DOI : 10.2174/138161210793563635

J. Dunford, The molecular target of nitrogen containing bisphosphonates: the molecular pharmacology of FPP synthase, Curr Phram Des, 2010.

L. Mitrofan, S. Auriola, H. Mönkkönen, and J. Mönkkönen, Assessment of Bishosphonate Activity In Vitro, Current Pharmaceutical Design, vol.16, issue.27, 2010.
DOI : 10.2174/138161210793563644

G. Moriceau, B. Ory, B. Gobin, F. Verrecchia, F. Gouin et al., Therapeutic Approach of Primary Bone Tumours by Bisphosphonates, Current Pharmaceutical Design, vol.16, issue.27, 2010.
DOI : 10.2174/138161210793563554

URL : https://hal.archives-ouvertes.fr/inserm-00511241

S. Syddall, P. Ottewell, and I. Holen, Combined Therapies of Bone Disease with Bisphosphonates, Current Pharmaceutical Design, vol.16, issue.27, 2010.
DOI : 10.2174/138161210793563590

E. Woodward and R. Coleman, Prevention and Treatment of Bone Metastases, Current Pharmaceutical Design, vol.16, issue.27, 2010.
DOI : 10.2174/138161210793563581

P. Clezardin and M. Massaia, Bisphosphonates in tumor immunotherapy, Curr Pharm Des, 2010.

T. Buijs-jeroen, K. Chantal, C. H. Van-der-pluijm, and . Gabri, Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates, Curr Pharm Des, 2010.

M. Lawson, J. Ashcroft, and P. Croucher, Bisphosphonates and the Treatment of Multiple Myeloma, Curr Pharm Des, 2010.

L. Goff, B. Guillot, P. Glémarec, J. Berthelot, J. Maugars et al., A comparison between bisphosphonates and other treatments for osteoporosis, Curr Pharm Des, 2010.

L. Goff, B. Berthelot, J. Maugars, Y. Romas, and E. , Alternative use of bisphosphonate therapy for rheumatic disease, Curr Pharm Des, 2010.